Mission
The Oklahoma Medical Research Foundation (OMRF) is a non-profit organization founded in 1946. It focuses on conducting research aimed at understanding and curing human diseases. Key areas of research include autoimmune disorders, cancer, Alzheimer's disease, and heart disease, with significant contributions to medical advancements such as the development of life-saving drugs and diagnostic tests.
Basic Information
Tax-Exempt
Founded in
1946
EIN
73-0580274
Total Assets
$463.8 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 3 of 3 goals
At a Glance
Major Breakthroughs in Autoimmune Disease Research
Learn how OMRF's discoveries are transforming treatments for autoimmune diseases.
Annual Research Forum
Join our research forums to hear from expert speakers in the biomedical field.
Become a Donor
Your support is crucial for ongoing research; consider donating today.
Impact Stats
Thousands
Number of lives impacted
Development of drug treatments for HIV/AIDS
OMRF researchers contributed to the creation of protease inhibition cocktails crucial for extending life for HIV/AIDS patients.
Over 5,000
Number of patients treated
Creation of Soliris
First treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH).
Over 100 countries
Clinics using the tests
Diagnostic tests for lupus and rheumatoid arthritis
Developed tests that are widely used in hospitals globally.
Upcoming Events
OMRF 2024-25 Research Forum
2024-12-12
Join our weekly research forum to learn from leading experts.
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
75
76
/100
Program Expense Ratio
93.74%
20
/20
Program Revenue Growth
6.96%
16
/20
Leverage Ratio
0.07241
20
/20
Working Capital Ratio
4.438
18
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2021
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 70.29M | 65.24% |
| Program Services | 25.75M | 23.90% |
| Investment Income | 13.05M | 12.11% |
| Sales of Non-Inventory Assets | -8.599M | -7.98% |
| Other Notable Sources | 1.756M | 1.63% |
| Total Revenue | 107.7M | 100.00% |
Related Nonprofits
Biomedical Research Institute of Southern California
Med Research
Medical Device Research
Chinese Biopharmaceutical Association-Usa Inc.
Med Research
Medical Device ResearchStowers Institute for Medical Research
Med Research
Medical Device ResearchBiomedical Research Foundation Medical Research 151
Med Research
Medical Device ResearchFogarty Institute for Innovation
Med Research
Medical Device Research